Growth and safety evaluation of infant formulae containing oligosaccharides derived from bovine milk: a randomized, double-blind, noninferiority trial.

BMC Pediatr · 2014 · PMC4297447 · PMID 25527244

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

did not reach statistical significancep = 0.08so close (0.05 < p ≤ 0.1)

Higher rates of discontinuations were observed in the BMOS-supplemented formula groups (36.4% in IF-BMOS; 34.7% in IF-BMOS + Pro) compared with the control formula group (23.8%), although the differences did not reach statistical significance (p = 0.08 for IF-BMOS versus control; p = 0.14 for IF-BMOS + Pro versus control).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.